Cargando…
Disrupting Circadian Rhythm via the PER1–HK2 Axis Reverses Trastuzumab Resistance in Gastric Cancer
Trastuzumab is the only approved targeted drug for first-line treatment of HER2-positive advanced gastric cancer, but the high rate of primary resistance and rapid emergence of secondary resistance limit its clinical benefits. We found that trastuzumab-resistant (TR) gastric cancer cells exhibited h...
Autores principales: | Wang, Jiao, Huang, Qiong, Hu, Xingbin, Zhang, Shuyi, Jiang, Yu, Yao, Guangyu, Hu, Kongzhen, Xu, Xin, Liang, Bishan, Wu, Qijing, Ma, Zhenfeng, Wang, Yawen, Wang, Chunlin, Wu, Zhenzhen, Rong, Xiaoxiang, Liao, Wangjun, Shi, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662874/ https://www.ncbi.nlm.nih.gov/pubmed/35255118 http://dx.doi.org/10.1158/0008-5472.CAN-21-1820 |
Ejemplares similares
-
Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2‐positive gastric cancer
por: Hu, Xingbin, et al.
Publicado: (2023) -
Shear stress activates ATOH8 via autocrine VEGF promoting glycolysis dependent-survival of colorectal cancer cells in the circulation
por: Huang, Qiong, et al.
Publicado: (2020) -
Adipocytes fuel gastric cancer omental metastasis via PITPNC1-mediated fatty acid metabolic reprogramming
por: Tan, Yujing, et al.
Publicado: (2018) -
Remodeling Chondroitin-6-Sulfate–Mediated Immune Exclusion Enhances Anti–PD-1 Response in Colorectal Cancer with Microsatellite Stability
por: Wu, Qijing, et al.
Publicado: (2022) -
MET transcriptional regulator/serine peptidase inhibitor kunitz type 1 panel operating through HGF/c‐MET axis as a prognostic signature in pan‐cancer
por: Xiang, Yi, et al.
Publicado: (2021)